Tech Company Financing Transactions
Chase Pharmaceuticals Funding Round
On 2/17/2016, Chase Pharmaceuticals raised $500 thousand in Series B funding from private investors.
Transaction Overview
Company Name
Announced On
2/17/2016
Transaction Type
Venture Equity
Amount
$500,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 13 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1825 K St. Northwest 520
Washington, DC 20006
USA
Washington, DC 20006
USA
Phone
Website
Email Address
Not Recorded
Overview
Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Siebert
Chief Medical Officer
Kathleen Clarence-Smith
Chief Scientific Officer
Thomas Chase
Browse more venture capital transactions:
Prev: 2/17/2016: Wavefront venture capital transaction
Next: 2/17/2016: Bux venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs